Scilex Holding (SCLX) Other Non Operating Income (2021 - 2026)

Scilex Holding (SCLX) recorded quarterly Other Non Operating Income of -$279000.0 in Q1 2026, down 100.34% quarter-over-quarter from $82.1 million in Q4 2025, and down 102.68% on a YoY basis from $10.4 million in Q1 2025.

Scilex Holding (SCLX) Other Non Operating Income (2021 - 2026) Analysis & Trends

Scilex Holding's Other Non Operating Income history runs 6 years deep, the most recent figure standing at -$279000.0 for Q1 2026.

  • In Q1 2026, Other Non Operating Income fell 102.68% year-over-year to -$279000.0; the TTM figure through Mar 2026 stood at $81.7 million (up 222.33% YoY), while the FY2025 annual figure was $21.8 million, up 25.45% from the prior year.
  • Other Non Operating Income was -$279000.0 for Q1 2026 at Scilex Holding, down from $82.1 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $82.1 million in Q4 2025 to a low of -$5.3 million in Q1 2023.
  • Historically, Other Non Operating Income has averaged $6.7 million across 5 years, with a median of -$2000.0 in 2025.
  • The sharpest annual moves came in 2022 and 2023: Other Non Operating Income plunged 4047.37% in 2022, then soared 13593.55% in 2023.
  • A 5-year view of Other Non Operating Income shows it stood at $3.0 million in 2022, then slumped by 67.71% to $972000.0 in 2023, then jumped by 1444.34% to $15.0 million in 2024, then surged by 447.09% to $82.1 million in 2025, then tumbled by 100.34% to -$279000.0 in 2026.
  • The last three Other Non Operating Income figures came in at -$279000.0 (Q1 2026), $82.1 million (Q4 2025), and -$2000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn
10 Scilex Holding 48.31 Mn -101.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -279,000.00
Dec 31, 2025 82.12 Mn
Sep 30, 2025 -2,000.00
Jun 30, 2025 -99,000.00
Mar 31, 2025 10.40 Mn
Dec 31, 2024 15.01 Mn
Sep 30, 2024 -46,000.00
Jun 30, 2024 -5,000.00
Mar 31, 2024 -457,000.00
Dec 31, 2023 972,000.00
Sep 30, 2023 4.25 Mn
Jun 30, 2023 -82,000.00
Mar 31, 2023 -5.25 Mn
Dec 31, 2022 3.01 Mn
Sep 30, 2022 31,000.00
Jun 30, 2022 -2.70 Mn
Mar 31, 2022 7.50 Mn
Dec 31, 2021 -9.86 Mn
Sep 30, 2021 1.16 Mn
Jun 30, 2021 68,400.00